The FDA announced a public workshop to be held on July 17, 2019 entitled “Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations”. The workshop was convened by Duke University’s Robert J. Margolis, MD, Center for Health Policy and further details on the agenda can be found here.

These slides where part of Session 3: Analytical Tools and Methods to Support Risk-Based Monitoring.


Download Slides

Watch a recording of the workshop here: (The recording is nolonger available from Duke Margolis - if I can find a new version it will be posted soon)

Further Reading On This Topic